StockWatch
·

COLGATE-PALMOLIVE (INDIA) LTD.

BSE: 500830

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
1.6K
+0.9%+12.0%
Expenditure
1.2K
+3.5%+13.8%
Net Profit
343.08
-2.9%+7.0%
OPM %
29.92%
-0.99pp-1.64pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00474.63949.251.4K1.9KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Premium Flywheel Spins, but Credibility Cracks Under Sequential Weakness

premiumisation · margin discrepancy · QoQ weakness

Result verdictFollow-upQ1 FY2721 Aug 20266 minFMCG

Colgate posts 12% sales growth, ₹343 Cr PAT; adjusted profit +11% as premiumisation drives a Q1 beat

fmcg · oral care · premiumisation

ResultsQ1 FY2729 Jul 20263 minFMCG

Testing the Momentum—Can Q1 Sustain FY26's 9% Growth as Rural Demand Stabilizes?

COLPAL · oral-care · premiumisation

Result previewQ1 FY2727 Jul 20263 minFMCG
Latest
Board Meeting29 Jul, 11:44 am

Colgate posts 12% sales growth, ₹343 Cr PAT; adjusted profit +11% as premiumisation drives a Q1 beat

Colgate-Palmolive (India) opened FY27 with standalone net sales up ~12% YoY to ₹1,591 Cr (revenue from operations ₹1,603 Cr including other operating income), comfortably beating the ~7–9% growth the Street had penciled in for the quarter and marking a clear acceleration on Q4 FY26's 9%. Reported net profit rose to ₹343 Cr from ₹321 Cr a year ago — a modest +7% headline — but on an adjusted basis, stripping the inverted-duty-structure GST charge and ₹3.3 Cr of organisational-restructuring severance, management pegs profit growth at +11% YoY, broadly in step with the topline. Growth was broad-based and volume-led: management cited high-single-digit toothpaste volume growth powered by the premium portfolio alongside a steady core, confirming the premiumisation-led thesis it set out on the Q4 concall. The margin story is a deliberate trade-off rather than a squeeze. Gross margin expanded ~110 bps YoY to 69.7% on Funding-the-Growth cost savings, but the company ploughed that gain straight back into brand building — advertising spend jumped ~34% YoY to ₹252 Cr — so net margin eased to ~21.1% of total income from ~22.1% a year earlier (and 21.9% in Q4). In other words, the compression sits on the A&P line by choice, not on the cost base. PAT margin on net sales (~21.6%) still ran well above the 18–19% the pre-result preview had flagged, so the print beat our bar on both topline and profitability, and resolves the watch items we set: 8–9% sales growth was exceeded at 12%, and margins held with a gross-margin surprise to the upside. Sequentially the quarter was near-flat — revenue +0.5% and PAT −2.9% versus Q4 FY26's ₹353 Cr — which is the seasonally correct read for FMCG and not the story; YoY is where the momentum shows. Management's tone stays confident: it reaffirmed the premiumisation and innovation agenda (MaxFresh Berry Blast, Total Active Prevention toothbrush launches) and framed calibrated pricing plus cost savings as the levers to protect margins against commodity-price volatility. The company gives no formal quantified guidance, but the qualitative outlook it offered last quarter — balanced volume-and-price growth led by premium — was confirmed by this print rather than contradicted.

29 Jul 2026, 11:44 am

Corporate Events

Board MeetingCOLPAL
2026
21Aug

Board Meeting

The Board of Directors noted the resignation of Ms. Prabha …

BSE Filing
Board MeetingCOLPAL
2026
29Jul

Board Meeting

The company has scheduled its 85th Annual General Meeting. …

BSE Filing
Board MeetingCOLPAL
2026
29Jul

Board Meeting

The company has scheduled its 85th Annual General Meeting ("…

BSE Filing
DividendCOLPAL
2026
1Jun

₹24 / share

BSE Filing
Board MeetingCOLPAL
2024
24Oct

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing
Board MeetingCOLPAL
2024
29Jul

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing
DividendCOLPAL
2024
23May

₹26 / share

BSE Filing
Board MeetingCOLPAL
2024
22Jan

Board Meeting

Consider and approve Intimation under Regulation 29 of SEBI …

BSE Filing
DividendCOLPAL
2023
6Nov

₹22 / share

BSE Filing
Board MeetingCOLPAL
2023
26Oct

Board Meeting

Approve and take on record the Unaudited Financial Results f…

BSE Filing